상세 보기
Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
- Lim, Hyung-Jun;
- KWAK, Kunye;
- Kim, Changgon;
- Choi, Yoon Seok;
- Park, Yong;
- ... Kim, Byung Soo;
- ... Ahn, Ki Hoon;
- ... Kang, Ka-Won
WEB OF SCIENCE
0SCOPUS
0초록
Background Splenectomy and thrombopoietin receptor agonists (TPO-RAs) are recommended second-line therapies for immune thrombocytopenia. Although guidelines recommend tailoring second-line treatments to patient characteristics, this approach is often unclear in real-world practice. Objectives We examined claims-based time to next treatment (TTNT) and safety outcomes after splenectomy or TPO-RA as a second-line therapy using nationally representative Korean claims data. Methods Patients diagnosed with immune thrombocytopenia between 2002 and 2021 were included. From the eligible cohort, we identified patients whose index second-line treatment was splenectomy (group 1) or TPO-RA without prior splenectomy (group 2). Propensity score matching was performed between patients in both groups who had received corticosteroids as first-line treatment. Results After matching, 447 group 1 and 57 group 2 patients were analyzed. Subsequent treatment was administered to 82.3% and 61.4% of patients in groups 1 and 2, respectively. Median TTNTs were 5.80 and 3.03 months in groups 1 and 2, respectively. Estimated TTNT curves diverged after 24 months, with a longer TTNT observed in the TPO-RA group. Pneumococcal infections occurred in 3.1% of patients in group 1 and none in group 2. Venous thromboembolism (VTE) occurred in 10.5% and 15.7% of patients in groups 1 and 2, respectively. The observed time to VTE was shorter in group 2 than in group 1. Conclusion Patients treated with TPO-RAs as a second-line therapy showed a longer TTNT after 24 months, whereas VTE occurred earlier in the TPO-RA group. However, these findings should be interpreted with caution because of residual confounding.
키워드
- 제목
- Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
- 저자
- Lim, Hyung-Jun; KWAK, Kunye; Kim, Changgon; Choi, Yoon Seok; Park, Yong; Kim, Byung Soo; Ahn, Ki Hoon; Kang, Ka-Won
- 발행일
- 2026-10
- 유형
- Article
- 권
- 10
- 호
- 7
- 언어
- ENG
- 출판사
- Wiley | International Society on Thrombosis and Haemostasis
- 발행국가
- 미국
- ISSN
- P 2475-0379